41 results
PRE 14A
SYRS
Syros Pharmaceuticals Inc.
12 Apr 24
Preliminary proxy
4:30pm
or at the election of the participant, in a manner that complies with Section 409A of the Code. A participant has no voting rights with respect to any RSU … , have a dilutive effect on earnings per share and on stockholders’ equity and voting rights. Furthermore, future sales of substantial amounts of our
424B5
SYRS
Syros Pharmaceuticals Inc.
19 Dec 23
Prospectus supplement for primary offering
4:53pm
including with respect to dividends and voting rights. Upon exercise of the pre-funded warrants, the holders will be entitled to exercise the rights … not have the rights or privileges of a holder of our common stock, including any voting rights, until the holder exercises the pre-funded warrant.
S
424B5
xxijvdz32zfnsv
1 May 23
Prospectus supplement for primary offering
4:06pm
8-K/A
EX-99.3
vt5e0k
30 Nov 22
Financial Statements and Exhibits
6:46pm
425
6xqm0fj 1kk4
15 Sep 22
Business combination disclosure
4:08pm
8-K
EX-99.1
u4jtf1tkbs
15 Sep 22
Departure of Directors or Certain Officers
4:06pm
424B3
h1bdw8 9ez
8 Aug 22
Prospectus supplement
5:47pm
S-4
EX-10.5
i76bk 2v04mj4b
18 Jul 22
Registration of securities issued in business combination transactions
7:58am
S-4
ri7ykcc0e10v9
18 Jul 22
Registration of securities issued in business combination transactions
7:58am